SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 517 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,086,823 | +38.0% | 589,615 | +25.2% | 0.03% | +35.0% |
| Q2 2023 | $90,650,317 | +50.3% | 471,009 | +58.2% | 0.02% | +42.9% |
| Q1 2023 | $60,300,223 | -49.7% | 297,823 | -68.1% | 0.01% | -51.7% |
| Q4 2022 | $119,798,384 | +97563.1% | 932,211 | +4.0% | 0.03% | -6.5% |
| Q3 2022 | $122,665 | -28.4% | 896,483 | -7.4% | 0.03% | -27.9% |
| Q2 2022 | $171,268 | -99.9% | 967,945 | -15.0% | 0.04% | +22.9% |
| Q1 2022 | $163,958,000 | +7.3% | 1,138,205 | +15.2% | 0.04% | +16.7% |
| Q4 2021 | $152,782,000 | -26.8% | 988,237 | -19.6% | 0.03% | -31.8% |
| Q3 2021 | $208,831,000 | +12.7% | 1,229,867 | +4.8% | 0.04% | +4.8% |
| Q2 2021 | $185,295,000 | +59.7% | 1,173,641 | +40.5% | 0.04% | +44.8% |
| Q1 2021 | $116,025,000 | -37.6% | 835,555 | -21.3% | 0.03% | -39.6% |
| Q4 2020 | $186,047,000 | – | 1,062,276 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |